Industry Insights

  1. Standardization And Flexibility In Aseptic Filling

    Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?

  2. The 4 Most Important Elements Of A Successful Sponsor-CDMO Relationship 1/28/2020

    When a sponsor contracts with a manufacturing organization, it takes on oversight beyond that within its own organization. These understated considerations play an important role in a successful relationship.

  3. The Critical Role Of Weight Uniformity In Tablet Manufacturing 7/11/2024

    For tablet manufacturers, tablet weight uniformity plays an essential role in ensuring pharmaceutical products deliver accurate amounts of key ingredients in a formulation.

  4. Combat Major Cell And Gene Therapy Manufacturing Regulatory Obstacles 8/8/2023

    As cell and gene therapies grow in the pharmaceutical industry, drug sponsors must determine how to successfully navigate evolving regulations, study design considerations, and a lack of animal models.

  5. Automation Without Robotics: Elimination Of Sample Transfer Steps 5/4/2023

    A study was conducted to evaluate the SampleGenie system and determine if it is suitable for replacing several manual process steps. Explore the methods and results of this investigation.

  6. "Human Error" Deviations: How You Can Stop Creating (Most Of) Them 10/9/2017

    In the time it takes you to read this article, the industry will generate (conservatively) about 115 new process deviations, and about 65 of them will be misclassified as having something related to “human error” as either the principal causal factor or one of the proximal causal factors.

  7. Expert Voices: Why Aren't QC Labs Fully Automated Yet? 10/4/2024

    Leading automation experts chime in on why QC labs, otherwise ideal for robotics, have been slow to adopt and standardize the technology.

  8. Making judgment calls at alliance margins 11/13/2000
    Increasing shareholder value doesn't always mean buying or selling assets—at least not for most small and medium-sized companies...
  9. December 2024 — CDMO Opportunities And Threats Report 1/2/2025

    Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

  10. Pharmaceutical Liquid Filling Systems — A Succinct Comparison And Selection Guide 1/14/2022

    View an attributes comparison of the primary strengths and weaknesses of the various filling systems based on the properties of the fill media, availability of additional functionality, filling tolerance, capital cost, and overall benefits and limitations.